139 results on '"Thiel, Falk C"'
Search Results
2. Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma
3. Role of tumour-free margin distance for loco-regional control in vulvar cancer—a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study
4. Clarifications concerning the commentary “Published analysis of contraceptive effectiveness of Daysy and DaysyView app is fatally flawed”
5. Endometriumkarzinom
6. Zervixkarzinom
7. Zervixkarzinom
8. Endometriumkarzinom
9. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor
10. Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie
11. Hormone replacement therapy and prognosis in ovarian cancer patients
12. RETRACTED ARTICLE: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
13. Comparison of re-operation rates and complication rates after total laparoscopic hysterectomy (TLH) and laparoscopy-assisted supracervical hysterectomy (LASH)
14. Comparison of reoperation rates, perioperative outcomes in women with endometrial cancer when the standard of care shifts from open surgery to laparoscopy
15. Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008
16. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis
17. Financing of certified centers: a willingness-to-pay analysis
18. Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians
19. The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center
20. Patterns and Trends of Herbal Medicine Use among Patients with Gynecologic Cancer
21. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer
22. Mitomycin C in Patients with Gynecological Malignancies
23. Results of the Zometa® Cost-Utility Model for the German Healthcare System Based on the Results of the ABCSG-12 Study
24. Low-Grade Endometrial Stromal Sarcoma - a Review
25. Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma
26. Retraction Note: Improving usability and pregnancy rates of a fertility monitor by an additional mobile application: results of a retrospective efficacy study of Daysy and DaysyView app
27. Low-Grade Endometrial Stromal Sarcoma - a Review
28. Common variants at 19p13 are associated with susceptibility to ovarian cancer (vol 42, pg 880, 2010)
29. Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
30. Chylous ascites after lymphadenectomy for gynecological malignancies
31. Correspondence (reply): In Reply
32. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor
33. Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases
34. Hysterectomy-a comparison of approaches
35. Zervixkarzinom
36. Endometriumkarzinom
37. Low-dose methotrexate treatment in ectopic pregnancy: a retrospective analysis of 164 ectopic pregnancies treated between 2000 and 2008
38. Phase II study of fulvestrant 250mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie
39. Financing of certified centers: a willingness-to-pay analysis
40. Is Laparoscopic Extirpation of the Cervical Stump After Laparoscopic Supracervical Hysterectomy Justified in Women with Incidentally Found Atypical Endometrial Hyperplasia?
41. The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center
42. Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System
43. In Reply
44. Hysterectomy
45. Neurokinin 1 receptor gene polymorphism might be correlated with recurrence rates in endometriosis
46. Zervixkarzinom.
47. Endometriumkarzinom.
48. Common variants at 19p13 are associated with susceptibility to ovarian cancer
49. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24
50. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.